BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lauko A, Lo A, Ahluwalia MS, Lathia JD. Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors. Semin Cancer Biol 2021:S1044-579X(21)00049-3. [PMID: 33640445 DOI: 10.1016/j.semcancer.2021.02.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Mishra VS, Patil S, Reddy PC, Lochab B. Combinatorial delivery of CPI444 and vatalanib loaded on PEGylated graphene oxide as an effective nanoformulation to target glioblastoma multiforme: In vitro evaluation. Front Oncol 2022;12:953098. [DOI: 10.3389/fonc.2022.953098] [Reference Citation Analysis]
2 Drakulic D, Schwirtlich M, Petrovic I, Mojsin M, Milivojevic M, Kovacevic-grujicic N, Stevanovic M. Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma. Cells 2022;11:2530. [DOI: 10.3390/cells11162530] [Reference Citation Analysis]
3 Di Bartolomeo S, Segatto M. Special Issue “Tumors of the Nervous System: New Insights into Signaling, Genetics and Therapeutic Targeting”. IJMS 2022;23:8700. [DOI: 10.3390/ijms23158700] [Reference Citation Analysis]
4 Gimple RC, Yang K, Halbert ME, Agnihotri S, Rich JN. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat Rev Cancer 2022. [PMID: 35710946 DOI: 10.1038/s41568-022-00486-x] [Reference Citation Analysis]
5 Wu Z, Wang X, Fang N, Lin Y, Zheng L, Xue Y, Cai S, Chen J, Lin N, Kang D. Automatic and Label-Free Analysis of the Microstructure Feature Differences Between Normal Brain Tissue, Low-Grade, and High-Grade Gliomas Using the Combination of Multiphoton Microscopy and Image Analysis. Front Phys 2022;10:865455. [DOI: 10.3389/fphy.2022.865455] [Reference Citation Analysis]
6 Bogusiewicz J, Kupcewicz B, Goryńska PZ, Jaroch K, Goryński K, Birski M, Furtak J, Paczkowski D, Harat M, Bojko B. Investigating the Potential Use of Chemical Biopsy Devices to Characterize Brain Tumor Lipidomes. Int J Mol Sci 2022;23:3518. [PMID: 35408879 DOI: 10.3390/ijms23073518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Quader S, Kataoka K, Cabral H. Nanomedicine for brain cancer. Adv Drug Deliv Rev 2022;182:114115. [PMID: 35077821 DOI: 10.1016/j.addr.2022.114115] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
8 Urbantat RM, Jelgersma C, Brandenburg S, Nieminen-Kelhä M, Kremenetskaia I, Zollfrank J, Mueller S, Rubarth K, Koch A, Vajkoczy P, Acker G. Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy. Int J Mol Sci 2021;22:11180. [PMID: 34681839 DOI: 10.3390/ijms222011180] [Reference Citation Analysis]
9 Tang DG, Kondo T. Cancer cell heterogeneity and plasticity: From molecular understanding to therapeutic targeting. Semin Cancer Biol 2021:S1044-579X(21)00251-0. [PMID: 34626799 DOI: 10.1016/j.semcancer.2021.10.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Troike KM, Acanda de la Rocha AM, Alban TJ, Grabowski MM, Otvos B, Cioffi G, Waite KA, Barnholtz Sloan JS, Lathia JD, Guilarte TR, Azzam DJ. The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients. Cancers (Basel) 2021;13:4525. [PMID: 34572751 DOI: 10.3390/cancers13184525] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Suryawanshi YR, Schulze AJ. Oncolytic Viruses for Malignant Glioma: On the Verge of Success? Viruses 2021;13:1294. [PMID: 34372501 DOI: 10.3390/v13071294] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]